Phase
Condition
Severe Premenstrual Symptom
Premenstrual Syndrome
Treatment
N/AClinical Study ID
Ages 18-45 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Chinese women of reproductive age 18-45 years (inclusive) with a diagnosis ofPremenstrual Dysphoric Disorder (PMDD)
Exclusion
Exclusion Criteria:
Any formal psychotherapeutic counselling within 1 month before the screening visit (Visit 1) or used medication for Premenstrual Syndrome (PMS) or Premenstrual DysphoricDisorder (PMDD) including, but not limited to hormones, bromocriptine, GnRH agonists,vitamin B6 (>100 mg), calcium supplements (> 1500 mg/day), anxiolytics andantidepressants during the 3 month period prior to Visit 1
Use of sleeping medication (including melatonin) for more than 3 days per month.
Pregnancy or less than 3 menstrual cycles since delivery, abortion or lactation beforestart of treatment
Obesity (body mass index or BMI > 30 kg/m2)
Hypersensitivity to any ingredient of the study drug
Study Design
Connect with a study center
Guangzhou, Guangdong 510405
ChinaSite Not Available
Wuhan, Hubei 430060
ChinaSite Not Available
Changsha, Hunan 410011
ChinaSite Not Available
Nanjing, Jiangsu 210029
ChinaSite Not Available
Dalian, Liaoning 116011
ChinaSite Not Available
Jinan, Shandong 250012
ChinaSite Not Available
Xi'an, Shanxi 710032
ChinaSite Not Available
Chengdu, Sichuan 610041
ChinaSite Not Available
Kunming, Yunnan 650032
ChinaSite Not Available
Hangzhou, Zhejiang 310003
ChinaSite Not Available
Beijing, 100191
ChinaSite Not Available
Tianjin, 300193
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.